Endovascular Case – November 2018
69 year old male with h/o DM, HTN, HLD, active smoker (1 ppd), with non healing left diabetic foot ulcer, s/p recent intervention of the LSFA ISR and left TMA. He presents for intervention of the distal touch down of the right Fem-tibial bypass graft (SVG). Left CFA access, 6 fr up and over sheath and PTA/DCB. On Plavix and Xeralto. Close U/S and clinical surveillance post intervention.
Management of SFA ISR CTO – May 2019
64 year old male with PMH of NIDDM, CKD, HTN, HLD, CAD s/p CABG on 11/1/2018 at LHH (3v), PAD, s/p multiple PTAs (last being 12/19/2018), former smoker (quit 2 months ago).
Ostial SFA CTO Intervention – April 2019
71 year old female with HTN, HLP, DM, complains of left LE claudication which progressed to resting pain (Rutherford 4).
Drug Coated Device Controversies post FDA Warning – March 2019
70 year old female with PMH of HTN, HLD, DM, Hypothyroidism, former smoker (quit 20 years ago), CAD s/p PCI of RCA,PAD s/p aorto-femoral bypass, and Carotid stenosis s/p left CEA (2015).
Critical Limb Ischemia, Right AT CTO Intervention – February 2019
86 year old female patient with HTN, HLD, NIDDM, Afib under NOAC, CAD s/p PCI and PAD, complex SFA CTO and BTK disease with reconstitution at the level of A. dorsalis pedis.